Bibliografía
1. -ESMO minimun clinical recommendations for diagnosis, treatment and follow-up of squamous cell carcinoma of head and neck (SCCHN). Annals of Oncology 2005; 16(1):62-63.
2. -Boring CC, Squires TS, Tong T. Cancer Statistics. Cancer.J Clin 1994; 44: 7-26.
3. -Zhang Z, Morgenstern H. Environmental tobacco smoking, mutagen sensitivity and Head and Neck cancer. Cancer epidemiology, biomarker and prevention 2000; 9:1043-49.
4. -Arias F, Villafranca E, Dueñas MT, Vera R. Factores pronósticos en el carcinoma de cabeza y cuello. Ann Sis San Navarra 2000;24(1):73-81
5. -Folkman J. Angiogénesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995; 1:27-31
6. -Liotta L, Kleinerman J, Saidel G. Quantitative relationships of vascular tumour cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 1974;34:997-1004.
7. -Folkman J. Tumor angiogenesis: therapeutic implications. N Eng J Med 1971;85:1182-86.
8. -Denekamp J. Angiogenesis, neovascular proliferation and vascular pathology as targets for cancer therapy. Br. J.Radiol 1993;66:181-96.
9. -Folkman J. What is evidence that tumor are angiogenesis dependent? J Nat Cancer Ins 1999;82:4-6
10. -O’Reilly MS, Folkman J. Darmancy of micrometastases balance proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1995; 1:149-53.
11. -Sharma RRA, Harris AL, Dalgleish AG,et al. Angiogenesis as a biomarker and target in cancer chemoprevention. Lancet Oncol 2001;2:726-31.
12. -Krebel RS. Tumor angiogenesis:past, presente and near future. Carcinogenesis 2000;21:505-15.
13. -Holngren I, McMahon G.VEGF receptor signilin in tumor angiogenesis. The Oncologist 2000;5(1):3-10.
14. -Desai SB,Libutti SK. Tumor angiogenesis and endothelial cell modulatory factors. J Inmunotherapy 1999;22(3):186-211.
15. -Folkman J. Angiogénesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1995; 1:27-31.
16. -Barrillari G, Albonici L, Franzese O, Modesti A, Liberati F, Barillari P,et al. The basic residues of placenta growth factor type 2 retriere sequestered angiogenic factors into a soluble form; implications for tumor angiogénesis. Am Pathol 1998:152(5):116-16
17. -Weidner N.Tumoral vascularity as a prognostic factor in cancer patients: the evidence continues of grow. J Pathol 1998;184:119-22
18. -Fox SB, Harris AL. Histological quantificacion of tumor angiogenesis. APMIS 2004;112:413-30.
19. -Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B. Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol. 2004;57(6):591-97.
20. -Sharma S, Sharma MC, Sarkar C Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis. Histopathology 2005;46(5):481-89.
21. -Uzzan B, Nicolas P, Cucherat M, Perret GY. Microvessel desndity as a prognostic factor in woman with breast cancer a systematic review of the literatura and meta-analysis. Cancer Res 2004;64:2941-55
22. -Takenaka K, Ogawa E, Oyanagi H, Wada H, Tanaka F. Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer. Cancer Epidemiology, biomarkers, and prevention 2005; :1972-75
23. -Hironaka S, Hasebe T, Kmijo T, Ohtsu A, Boku N, Yoshida S, et al. Biopsy specimen microvessel density is useful prognostic marker in patients with T2-4M0 esophageal cancer trated. Clin C Res 2002;8:124-30.
24. -Niedergethman M, Hildenbrand R, Wostbrock B, Hartel M, Sturm JW, Richter, et al. High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas. Pancreas 2002; 25(2):122-29
25. -Orre M, Lotfi-Miri M, Rogers Paw. Increased microvessel density in mucinous compared with malignat serous and beningn tumours of the ovary. Br J Cancer 1998;77:2204-9.
26. -Obermar A, Temper C, Wasicky R, Kaider A, Hefler L, Kainz R. prognostic significance of tumor angiogenesis in endometrial cancer. Endometrial tumor angiogenesis 1999;93(3):367-91.
27. -Morinaga S, Imada T, Shimizu A, Akaike M, Sugimasa Y, Takemiya S, Takanasa Y. Angiogenesis in hepatocelular carcinoma as evaluated by alpha smooth muscle actin inmunohistochemestry. Hepato-gastroenterology 2001;48:224-28.
28. -Williams JK, Carlson GW, Cohen C, Derose PB, Hunter S, Jurkiewicz MJ. Tumor angiogenesis as prognostic factor in oral cavity tumors. Am J Surg 2000;168:373-80
29. -Maeda T, Matsumura S, Hiranuma H. Vascular endothelial growth factor in human oral squamous cell carcinoma its associated with tumor progression and p53 gene status. J Clin Pathol 1998;51:771-75
30. -Salven P, Heikkila P, Anttonen A, Kajanti M Joensuu H. Vascular endotelial growth factor in squamous cell head and neck carcinoma: expression and prognostic significance. Mod Pathol 1999;10:1128-33
31. -Fleming ID, Cooper JS, Hensen DE, Hutter RV, Kennedy BJ, Murphy GP, et al AJCC Cancer Staging Manual. 5th ed. Philadelphia: Lippincott, 1997.p.342-56
32. -Weidner N, Semple JP, Welch WR. Tumor angiogenesis and metastasis correlation in anvsive breast carcinoma N Engl J Med 1991;324:1-8.
33. -Mattern J, Kallinowski F, Herfarth C. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 1996;67:20-23
34. -Mouvsas B, Champman JD, Greenberg RE. Increassing levels of hypoxia in prostate carcinoma correlate significantly with increased clinical stage and patient age: an Eppendorf pO(2) study. Cancer 2000;89:2018-24
35. -Harrinson LKumar P. Impact of anemia in patients with head and neck cancer. The Oncologist 2000;5(2):13-18.
36. -Eberhard A, Kahlert S, Goede V, Hemmerlein B, Plate KH, Augustin H. Heterogeneity of angiogenesis and blood vesse maturation in human tumors:implications for antiangogenic therapies. Cancer Res 2004;60:1388-93
37. -Less JR, Skalak TC, Sevick EM, Jain RK. Microvascular architecture in mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 1991;51:265-73.
38. -Harrinson LB, Chadha M, Hill RJ. Impact of tumor hypoxia and anemia an radiation therapy outcomes. The Oncologist 2002;7:492-508
39. -Dunphy F, Stack B, Boyd J, Dunleavy T, Kim H, Dunphy C. Microvessel density in advanced head and neck squamous cell carcinoma before and after chemotherapy. Anti C Res 2002;22:1755-58
40. -Duff S, Chenggang LI, Garland JM, Kumar S. CD 105 is important for angiogenesis evidence and potenctial applications. The FASEB Journal 2003;17:984-92.
41. -Kamijo T, Yokose T, Hasebe T, Yonou H, Sasaki S, Hasayi R, et al. Potential role of microvessel density in predicting radiosensitivity of T1 and T2 stage laryngeal squamous cell carcinoma treated with radiotherapy. Clin Cancer Res 2000;6:3159-65
42. -Teppo H, Soini Y, Melkko J, Koivunen P, Alho OP. Prognostic factors in laryngeal carcinoma:the role of apoptosis, p53, proliferation and angiogenesis APMIS 2003;111:451-57
43. -Zatterstrom UK, Brun E, Willen R, Kjellen E, Wennerberg J. Tumor angiogenesis and prognosis in squamous cell carcinoma of the head and neck. Head and Neck 1995;17:312-18.
44. -Gasparini G, Weidner N, Matuta S, Pozza F, Borracchi P, Mezzetti M, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous cell carcinoma . Int J Cancer1993; 55: 739-44.
45. -Klijaneinko J, El-Nagger AK, De Braud F. Tumor vascularization, mitotic index, histopathologic grade, and DNA ploidy in the assessment of 114 head and neck squamous cell carcinomas. Cancer 1995;75:1649-56.
|